chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022; Received expired  Monovalent vaccine after 30 day beyond use date; Received expired  Monovalent vaccine after 30 day beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022) and NO ADVERSE EVENT (Received expired  Monovalent vaccine after 30 day beyond use date) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Sep-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date). On 26-Sep-2022, the patient experienced NO ADVERSE EVENT (Received expired  Monovalent vaccine after 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022). On 27-Sep-2022, EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date) and NO ADVERSE EVENT (Received expired  Monovalent vaccine after 30 day beyond use date) outcome was unknown. At the time of the report, PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (Received expired  Monovalent vaccine after 30 day beyond use date) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022).    No relevant concomitant medications were reported.  The vial was initially stored in the refrigerator on 22-Aug-2022. Patient received expired Moderna COVID-19 vaccine after 30 day beyond use date 22-Sep-2022. There was unbroken cartons on vial. The vial size of adult was 5.5 ml. The vial did not undergo any temperature excursions. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2022: Live significant follow received contains narrative updated.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022; No adverse event; Received expired  Monovalent vaccine after 30 day beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Sep-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received expired  Monovalent vaccine after 30 day beyond use date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 22-Aug-2022 and administered on 23-Sep-2022).    Concomitant medication information was not provided by the reporter.  The vial was initially stored in the refrigerator on 22-Aug-2022. Patient received expired Moderna COVID-19 vaccine after 30 day. Beyond use date was reported as 22-Sep-2022.  There was unbroken cartons on vial. The vial size of adult was 5.5 ml. The vial did not undergo any temperature excursions.  Treatment information was not provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Sep-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medications were reported.  The pharmacist states they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11 years.  No treatment medications were reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse event; Adults received 0.5 ml of Moderna vial intended for ages 6-11 instead of bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Adults received 0.5 ml of Moderna vial intended for ages 6-11 instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Sep-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Adults received 0.5 ml of Moderna vial intended for ages 6-11 instead of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Adults received 0.5 ml of Moderna vial intended for ages 6-11 instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Adults received 0.5 ml of Moderna vial intended for ages 6-11 instead of bivalent booster).    No concomitant medications were reported. It was stated that they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11. The dosage was 0.5 ml. No treatment medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medications were reported. The pharmacist states they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11 years. No treatment medications were reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; They wanted the bivalent booster, but received the 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (They wanted the bivalent booster, but received the 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (They wanted the bivalent booster, but received the 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (They wanted the bivalent booster, but received the 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (They wanted the bivalent booster, but received the 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medication were reported.  The pharmacist stated they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11. Reporter stated that they were figuring out what they need to do - revaccinate or wait for a while.  Treatment medication information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; The pharmacist accidentally gave a group of people the wrong dosage of the Moderna booster at a dose of 0.5ml. They wanted the bivalent booster, but they gave the one intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (The pharmacist accidentally gave a group of people the wrong dosage of the Moderna booster at a dose of 0.5ml. They wanted the bivalent booster, but they gave the one intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (The pharmacist accidentally gave a group of people the wrong dosage of the Moderna booster at a dose of 0.5ml. They wanted the bivalent booster, but they gave the one intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (The pharmacist accidentally gave a group of people the wrong dosage of the Moderna booster at a dose of 0.5ml. They wanted the bivalent booster, but they gave the one intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (The pharmacist accidentally gave a group of people the wrong dosage of the Moderna booster at a dose of 0.5ml. They wanted the bivalent booster, but they gave the one intended for ages 6-11).    No concomitant information was reported.  No treatment information was provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event; adult received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adult received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adult received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adult received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adult received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medication were reported. The pharmacist stated they accidentally gave the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11. No treatment information was provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medication were reported.  The pharmacist stated they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11.  No treatment information was provided by the reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). On 27-Sep-2022, WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) outcome was unknown. At the time of the report, NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medications were reported.  The pharmacist states they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11 years.  No treatment medications were reported.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 97-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient received bivalent vaccine for their first dose of a Primary Series of the Moderna covid-19 vaccine; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine for their first dose of a Primary Series of the Moderna covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine for their first dose of a Primary Series of the Moderna covid-19 vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine for their first dose of a Primary Series of the Moderna covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine for their first dose of a Primary Series of the Moderna covid-19 vaccine).    No concomitant medications were provided by the reporter. The Nurse did not have any other information as she was calling on behalf of a Pharmacy where the error occurred. No age or date of birth was known.  No treatment medications were provided by the reporter.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; adults received 0.5 ml of Moderna vial intended for ages 6-11; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (adults received 0.5 ml of Moderna vial intended for ages 6-11).    No concomitant medications were reported.  The pharmacist states they accidentally gave a group of people the wrong dosage of the Moderna booster. They wanted the bivalent booster, but they gave the one intended for ages 6-11 years.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Headache, Myalgia
Clinical narrative: soreness behind the eyes; experiencing chills; body aches; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of EYE PAIN (soreness behind the eyes), CHILLS (experiencing chills), MYALGIA (body aches) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (soreness behind the eyes), CHILLS (experiencing chills), MYALGIA (body aches) and HEADACHE (Headache). At the time of the report, EYE PAIN (soreness behind the eyes), CHILLS (experiencing chills), MYALGIA (body aches) and HEADACHE (Headache) outcome was unknown.            Concomitant product use was not provided by the reporter.  It was reported that patient received Moderna COVID-19 vaccine on Tuesday and last night patient was telling she had been experiencing chills, body aches, soreness behind the eyes and headaches.  Treatment information was not provided.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; Patient received first dose on 18-Feb-2021 and second dose on 01-Apr-2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 18-Feb-2021 and second dose on 01-Apr-2021) and NO ADVERSE EVENT (No adverse event) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 038K20A) for COVID-19 prophylaxis.     Patient had no known allergies to medications, food and other products. It was unknown if patient was diagnosed or tested positive for COVID-19. It was unknown if patient was  diagnosed acute illness at the time of vaccination and or up to one month before.  The patient's past medical history included Drug therapy (Long term) since an unknown date. Previously administered products included for Drug use for unknown indication: Aspirin (Low dose(aspirin) 81mg tablet delayed release) until 12-Jun-2014. Past adverse reactions to the above products included No adverse event with Aspirin. Concurrent medical conditions included Hypertensive heart disease (without congestive heart failure), Type 2 diabetes mellitus (without complication), Hyperlipidemia, Hypothyroidism, Diabetic neuropathy (due to type 2 diabetes mellitus), Chronic kidney disease (due to type 2 diabetes mellitus), Alzheimer's disease and Vitamin D deficiency.   On 18-Feb-2021 at 2:01 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Apr-2021 at 10:53 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 01-Apr-2021 at 10:53 AM, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 18-Feb-2021 and second dose on 01-Apr-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 18-Feb-2021 and second dose on 01-Apr-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 18-Feb-2021 and second dose on 01-Apr-2021).    No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-645743 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperlipidaemia, Inappropriate schedule of product administration
Clinical narrative: Hyperlipidemia; First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021; This spontaneous case was reported by a nurse and describes the occurrence of HYPERLIPIDAEMIA (Hyperlipidemia) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 038K20A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Bystolic (10mg tablet) until 12-Jun-2014. Past adverse reactions to the above products included No adverse event with Bystolic. Concurrent medical conditions included Drug allergy (Allergy to hydrochlorothazide), Drug allergy (Allergy to Norvasc), Drug allergy (Allergy to Percocet), Sulfonamide allergy (Allergic to sulfa), Hypertensive heart disease (Hypertensive heart disease without congestive heart failure) since 24-Feb-2020, Type 2 diabetes mellitus (Type 2 diabetes mellitus without complication) since 24-Feb-2020, Gastroesophageal reflux disease (Gastroesophageal reflux disease without esophagitis) since 08-Mar-2019, Overweight since 06-Mar-2018 and Anxiety since 08-Mar-2019.   On 18-Feb-2021 at 2:02 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Apr-2021 at 10:55 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 01-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021). On 08-Nov-2021, the patient experienced HYPERLIPIDAEMIA (Hyperlipidemia). At the time of the report, HYPERLIPIDAEMIA (Hyperlipidemia) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was provided.   This case was linked to MOD-2022-645684 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No Adverse event; Patient was administered Moderna COVID-19 vaccine for 6-11 years, instead of the bivalent Moderna booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine for 6-11 years, instead of the bivalent Moderna booster) and NO ADVERSE EVENT (No Adverse event) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine for 6-11 years, instead of the bivalent Moderna booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine for 6-11 years, instead of the bivalent Moderna booster) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine for 6-11 years, instead of the bivalent Moderna booster).    No concomitant medications were reported. The patient had not reported an adverse reactions. No treatment information was provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Incorrect Moderna product administered to patients; No Adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Incorrect Moderna product administered to patients) and NO ADVERSE EVENT (No Adverse event) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Incorrect Moderna product administered to patients) and NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Incorrect Moderna product administered to patients) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Incorrect Moderna product administered to patients).    Concomitant medications were not reported. It was stated that a provider at their facility administered the pediatric COVID-19 for 6-11 years to 3 patients, instead of the bivalent booster (Lot #: 064A22A, Expiration date: 24NOV2022). The correct dosage of 0.5 mL was administered but the product was incorrect. No treatment information was provided by the reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No Adverse event; administered the pediatric Moderna COVID-19 for 6-11 years to 3 patients, instead of the bivalent Moderna booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (administered the pediatric Moderna COVID-19 for 6-11 years to 3 patients, instead of the bivalent Moderna booster) and NO ADVERSE EVENT (No Adverse event) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (administered the pediatric Moderna COVID-19 for 6-11 years to 3 patients, instead of the bivalent Moderna booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (administered the pediatric Moderna COVID-19 for 6-11 years to 3 patients, instead of the bivalent Moderna booster) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (administered the pediatric Moderna COVID-19 for 6-11 years to 3 patients, instead of the bivalent Moderna booster).    No concomitant medications was reported.  The patient has not reported an adverse reactions at that point.  No treatment drug details was reported.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Chills, Dry mouth, Fatigue
Clinical narrative: Dry mouth; Joint pain; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (Dry mouth), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, DRY MOUTH (Dry mouth), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Tested positive for covid on 17-Jan-2022; Lack of drug effect; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for covid on 17-Jan-2022) and DRUG INEFFECTIVE (Lack of drug effect) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 015M20A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Livalo (Livalo(pitavastatin) 4 mg tablet - Status: Inactive - Prescribed by: DOCTOR) until 12-Jun-2014. Past adverse reactions to the above products included No adverse event with Livalo. Concurrent medical conditions included Diabetes mellitus, Polyneuropathy (Polyneuropathy due to diabetes mellitus), Gastrooesophageal reflux disease (Gastrooesophageal reflux disease without esophagitis), Vitamin D deficiency, Obstructive sleep apnea syndrome, Hypothyroidism, Mixed hyperlipidaemia, Overactive bladder, Hypomagnesemia, Overweight, Drug allergy (Tramadol) and Drug therapy (Long-term drug therapy).   On 09-Mar-2021 at 4:37 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 06-Apr-2021 at 3:59 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 17-Jan-2022, the patient experienced COVID-19 (Tested positive for covid on 17-Jan-2022) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (Tested positive for covid on 17-Jan-2022) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jul-2020, SARS-CoV-2 test: (Positive) Positive. On 17-Jan-2022, SARS-CoV-2 test: (Positive) Positive.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included onetouch delica lancest 33 gauge filled on 12-Aug-2019 and onetouch ultra blue test strip filled on 12-Aug-2019.  Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-645838 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; Dose 1 and Dose 2 administered 40 days apart; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 and Dose 2 administered 40 days apart) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Shingrix (Lot number: E344C, Route IM and Dose number 2 of 2) on 16-Nov-2021. Past adverse reactions to the above products included No adverse event with Shingrix. Concurrent medical conditions included Mixed hyperlipidemia (onset more than 3 years), Hypertensive heart disease (without congestive heart failure more than 3 years), Gastrooesophageal reflux disease (without esophagitis, onset more than 3 years), Allergy to antibiotic (Cefdinir) and Sulfonamide allergy (sulfa). Concomitant products included HYDROCHLOORTHIAZIDE from 17-Aug-2022 to an unknown date, IRBESARTAN from 17-Aug-2022 to an unknown date, VITAMINS NOS (MULTIPLE VITAMIN) from 18-May-2022 to an unknown date, OMEPRAZOLE from 16-Nov-2021 to an unknown date, CITRIC ACID, POTASSIUM CITRATE (POTASSIUM CITRATE [CITRIC ACID;POTASSIUM CITRATE]) from 29-Aug-2022 to an unknown date, PRAVASTATIN from 17-Aug-2022 to an unknown date and PARACETAMOL (TYLENOL) from 11-Apr-2020 to an unknown date for an unknown indication.   On 08-Apr-2021 at 3:47 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 18-May-2021 at 3:12 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 18-May-2021 at 3:12 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 and Dose 2 administered 40 days apart). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 and Dose 2 administered 40 days apart) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 and Dose 2 administered 40 days apart).    It was reported that there were not known or reported adverse events. No treatment medications were reported.   This case was linked to MOD-2022-645658 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: Pfizer hits harder than Moderna, and this wasn't as bad as 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (Pfizer hits harder than Moderna, and this wasn't as bad as 2nd shot) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Day of the vaccine and day after were fine, also flu- life exhaustion for 2-3 days after, and fibromyalgia flared.), Pfizer (Day of the vaccine and day after were fine, also flu- life exhaustion for 2-3 days after and and fibromyalgia flared.). Past adverse reactions to the above products included Fibromyalgia with Pfizer; and Flu like symptoms with PFIZER BIONTECH COVID-19 VACCINE.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Pfizer hits harder than Moderna, and this wasn't as bad as 2nd shot). At the time of the report, IMMUNISATION REACTION (Pfizer hits harder than Moderna, and this wasn't as bad as 2nd shot) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications was reported.  The patient received Pfizer/ flu vaccine 1.5 weeks ago. The day of vaccination and day after were fine. The patient had flu- like exhaustion for 2-3 days after, and fibromyalgia was flared. The patient stated that, Day 4 was like magic was fine and also informed that Pfizer vaccine hits harder than Moderna, but it was not bad as 2nd Pfizer vaccine.  No treatment drug details was reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: get COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (get COVID) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2022, the patient experienced COVID-19 (get COVID). At the time of the report, COVID-19 (get COVID) outcome was unknown.            Patient received unknown concomitant drug.   No treatment medications were reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Patient received Bivalent booster instead of Primary series of Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received Bivalent booster instead of Primary series of Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7165B) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Sep-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received Bivalent booster instead of Primary series of Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received Bivalent booster instead of Primary series of Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received Bivalent booster instead of Primary series of Moderna COVID-19 vaccine).    No concomitant medications were reported.  The patient informed the pharmacy staff that after being vaccinated with the Bivalent booster that she never had any COVID-19 vaccine previously. . No treatment information was reported.; Sender's Comments:  :CMOD22-04042 (crosslink case)